TP53 and ovarian carcinoma: The usefulness of p53-AAbs as prognostic biomarkers in clinical outcome of ovarian cancer, in particular, has been poorly investigated; the role of p53-AAbs is still controversial but critical in understanding their function in the immune surveillance of cancer [40].